Back to Health

How Long Does Vaccine Protection Actually Last?

How Long Does Vaccine Protection Actually Last?
Bareback Guide 13 March 2026

How long a vaccine protects you for varies considerably, and the answer is complicated by a distinction people rarely hear about: measurable antibody levels falling is not the same as protection failing. Immune memory can persist long after antibodies become undetectable, and the body can mount a rapid response on re-exposure. That is why boosters are recommended for some vaccines and not others despite antibodies declining for both.

Hepatitis A

Two doses are thought to give protection for at least twenty-five years, and modelling suggests it may be lifelong. No routine booster is recommended for healthy adults who completed the two-dose course. The second dose is the one that converts short-term protection into long-term protection, which is why leaving a course half-finished matters.

Hepatitis B

For healthy adults who responded to a primary course, protection is considered long lasting and no routine booster is recommended, even though antibody levels commonly fall below the measurable threshold over the years. Immune memory does the work. The exceptions are people who are immunosuppressed or living with HIV, who may have levels monitored and boosters given, and people at continued occupational risk, where a single booster around five years after the primary course is sometimes used.

HPV

Follow-up studies now extend well over a decade with no evidence of protection waning, and no booster is recommended. The vaccine appears to produce unusually durable antibody levels, which is one reason the schedule has been reduced over time from three doses to fewer for most people.

Mpox

This is the least certain, because the vaccine has only been used at scale in this context since 2022. Two doses give substantial protection against symptomatic infection, and whether a booster will eventually be recommended is still being assessed. Anyone who had a single dose during the initial rollout and never returned should complete the course, since one dose is the weaker position rather than a shorter-lasting one.

The meningococcal B vaccine

Protection against meningococcal disease is thought to wane over a few years. Its partial effect against gonorrhoea, estimated at around a third, is likewise expected to be relatively short lived, and whether repeat doses will be recommended for that purpose is not yet settled. This is a good reason not to treat it as a lasting solution to gonorrhoea risk.

Should you check your antibody levels?

Generally no, except for hepatitis B, where a post-vaccination level identifies the one in ten people who did not respond at all. Checking levels years later for other vaccines produces numbers that are hard to interpret and often leads to unnecessary boosters. If you are immunosuppressed or living with HIV, your clinic will take a different approach and may monitor more actively.

What if you do not know what you have had?

Common, and not a disaster. Clinics hold records of what they gave you but not what a GP or another service gave you years ago. If your history is unclear, the usual approach is either a blood test to check for existing immunity, which works well for hepatitis A and B, or simply giving the course, since repeating a vaccine you have already had is not harmful. Do not let uncertainty become a reason to have nothing.

The practical position

Complete every course you start, ask for a hepatitis B response check afterwards, and keep a note of dates somewhere you can find them. For most people that is the whole of it, and no further action is needed for years. If your immune status changes, or you start a new medication that suppresses immunity, raise the vaccine question again at that point.

Does having an infection extend protection?

For hepatitis A and B, natural infection gives lasting immunity in its own right, so someone who has had hepatitis A does not need the vaccine. For HPV, having had one strain gives no useful protection against the other eight covered by the vaccine. For gonorrhoea, infection leaves no immunity at all, which is why the partial protection from the meningococcal B vaccine is the only thing available.

What happens if you have a dose you did not need?

Nothing harmful. Giving a vaccine to someone already immune is not dangerous, and it is often the pragmatic choice when records are missing. This is worth knowing because uncertainty about past doses is extremely common and should not become a reason to remain unprotected.